TESTAGEN
Extremely limited research base with no human clinical trials. Interesting theoretical framework but essentially unproven in practice.
Primarily investigated by researchers studying bioregulator peptides in Eastern European anti-aging institutes and longevity clinics.
Since Feb 2026
2 total
What is TESTAGEN?
Developed as part of the Russian bioregulator peptide series, this tetrapeptide targets reproductive tissue health in aging research. Scientists investigate its role in maintaining testicular cell function as testosterone levels naturally decline with age. Most research focuses on its tissue-specific regulatory properties rather than direct hormonal effects.
Unlike direct hormone replacement, Testagen appears to work at the cellular level by influencing gene expression in testicular tissue. The peptide contains four amino acids that may help regulate protein synthesis and cellular repair processes specific to Leydig cells, which produce testosterone. Think of it as providing maintenance instructions to aging reproductive cells rather than flooding the system with external hormones.
What the Research Shows
Only 2 studies exist, both in animal models, making any conclusions about human effects purely speculative.
Notable Studies
Dobriţescu A, Samide A, Cioateră N et al. · Molecules (2025)
In Vitro
Fedoreyeva LI, Kireev II, Khavinson VKh et al. · Biochemistry (Mosc) (2011)
In Vitro
Reported Benefits
Regulatory Status
Last verified: Feb 2026
Related Peptides
This information is for research purposes only and does not constitute medical advice. Always consult a licensed physician before using any peptides.